Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 1997

View Archived Issues

New alpha1-adrenoceptor antagonist evaluated

Medtronic and Somnus to codevelop snoring and sleep apnea therapy

Allelix adds two neuropharmaceutical development programs in Q2 1997

Allergan: Q1 1997 highlights

Genentech: Q1 1997 highlights

Warner-Lambert reaffirms goal of average EPS growth in mid-teens for balance of century

Neurotrophic/neuroprotective agents described by Synthelabo

Allergan claims prostaglandin derivatives with vasodilating activity

Substance P and bradykinin antagonists from Kyowa Hakko

MiniMed and Trimeris collaborate to deliver HIV therapy

Roussel Uclaf claims new cephalosporins

NovaDx discovers osteoporosis drug opportunities

Biosource awarded grant for human therapeutic protein production

Antitumor agents described by Sagami

PRIZM announces gene targeting results

BTG licenses Campath-1H to LeukoSite

Shareholder meeting set for Vaxel/Zynaxis merger

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

CoCensys discovers potent, water-soluble allosteric modulators of GABA-A receptor

Titan issued U.S. patent for cancer vaccine

Lilly prepares water-soluble echinocandin antifungal agents

Mylan Laboratories's Acyclovir receives FDA approval

Novel marine antioxidant described by UNC researchers

Bioniche reports positive clinical results for Regressin

Amino-ketones from Roche found to lower cholesterol levels in animals

Mimetix initiates clinical trial with injectable form of naproxen

Potent, selective beta3-agonist from Merck & Co.

Demeter reports results with Peptidyl MIM in animal model of prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...